Chapter IV.5. What is the Evidence that a Dementia Treatment Works?
- Nawab Qizilbash MBChB, MRCP, MSc, DPhil (Oxon)1,2
Published Online: 14 JAN 2008
Copyright © 2003 by Blackwell Science Ltd
Evidence-based Dementia Practice
How to Cite
Leber, P., Millson, D., Jolley, D., Ward, H., Qizilbash, N. and Schneider, L. S. (2003) What is the Evidence that a Dementia Treatment Works?, in Evidence-based Dementia Practice (ed N. Qizilbash), Blackwell Science Ltd, Oxford, UK. doi: 10.1002/9780470752340.ch30
Visiting Professor of Geriatric Medicine, Hospital Universitario GM-Cantoblanco, 280049 Madrid, Spain
Member of Green College, Oxford University, Oxford, UK
- Published Online: 14 JAN 2008
- Published Print: 1 JAN 2003
Print ISBN: 9780632052967
Online ISBN: 9780470752340
This chapter contains section titled:
The FD & C Act: its aims, provisions and enforcement by the FDA
Regulations and guidelines
The decision to develop antidementia guidelines
The guidelines development effort
Pseudospecific antidementia claims
Vetting of the proposed approach
Sources of dissatisfaction with the proposed guidelines
Looking to the future
Background: the UK societal framework for the purchasing and commissioning of drug treatments for AD
What are the issues for purchasing an Alzheimer's drug in the USA?
Appropriate situations for
Inappropriate situations for
of-1 trial feasible in dementia?
Practical aspects of conducting
of-1 trial appropriate for dementia, MCI and age-related cognitive decline?
Can I conduct
of-1 trials in my practice?
Choosing outcomes to assess effects
Evaluation of response and stopping rules